Yukiko Ozaki

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Tokyo
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Takashi Futaki, as Attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Yukiko Ozaki

Form 4 holding CHRO (Chief Human Resources Officer) and CHO (Chief Health Officer)

NOMURA HOLDINGS INC

Security class
Common Stock
Shares / value
21,019
Estimated value
$184,546
Report date
25 Aug 2026
Price
$8.78
Ownership
Direct
Form 4 holding CHRO (Chief Human Resources Officer) and CHO (Chief Health Officer)

NOMURA HOLDINGS INC

Security class
Common Stock
Shares / value
75
Estimated value
$655
Report date
25 Aug 2026
Price
$8.78
Ownership
Held in officers' stock ownership plan
Form 4 holding CHRO (Chief Human Resources Officer) and CHO (Chief Health Officer)

NOMURA HOLDINGS INC

Security class
Restricted Stock Units
Shares / value
7,600
Estimated value
Report date
27 Apr 2026
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount
Form 4 holding CHRO (Chief Human Resources Officer) and CHO (Chief Health Officer)

NOMURA HOLDINGS INC

Security class
Notional Stock Units
Shares / value
4,031
Estimated value
Report date
25 May 2026
Price
Ownership
Direct
Underlying class
Common stock
Underlying amount

Insider Reports Filed by Yukiko Ozaki

3 NMR

NOMURA HOLDINGS INC

Report period
18 Mar 2026
Transactions
0
Transaction value
$0
Accepted by SEC
18 Mar 2026, 09:42
Role
Chief Human Resources Officer and Chief Health Officer Exhibit 24: Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .